E. Boesen

681 citations
16 papers · 533 indexed · h-index 10

Impact in

Papers in

E. Boesen

15 papers receiving 455 citations

Peers

E. Boesen
Comparison fields: 5 of 77
  • Reproductive Medicine 107
  • Obstetrics and Gynecology 48
  • Infectious Diseases 111
  • Oncology 153
  • Hematology 55
Replace F Oberling with:
F Oberling France
Keith Sacco United States
Ara Chalvardjian Canada
M.‐G. Damber Sweden
S. Segal Israel
Kadri Güven Türkiye
Richard J. Hirschman United States
J Brock Germany
Swati Garg Canada
Deepa Reddy United States
E. Boesen relative to F Oberling France F Oberling's profile →
Citations per field
00.5×4.3×
F Oberling · 1×
Citations per year

Countries citing papers authored by E. Boesen

Since Specialization
Citations

This map shows the geographic impact of E. Boesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Boesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Boesen more than expected).

Fields of papers citing papers by E. Boesen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Boesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Boesen. The network helps show where E. Boesen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside E. Boesen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Boesen Line = papers co-authored together E. Boesen links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 19938
2 19911
3 199028
4 198410
5 198348
6 19833
7 1982126
8 197720
9 1977124
10 197455
11 19734
12 19726
13
Cytotoxic drugs in the treatment of cancer
196924
14 196240
15 196228
16 19618

About E. Boesen

E. Boesen is a scholar working on Reproductive Medicine, Pathology and Forensic Medicine, Oncology, Genetics and Hepatology, having authored 16 papers that have together received 533 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Lung Cancer Treatments and Mutations (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Herpesvirus Infections and Treatments (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Reproductive Medicine (107 citations), Obstetrics and Gynecology (48 citations), Infectious Diseases (111 citations), Oncology (153 citations) and Hematology (55 citations). E. Boesen has collaborated with scholars based in United Kingdom, Australia and Singapore. Frequent co-authors include H. J. G. Bloom, Harry S. Shannon, Rebecca M. Pearson, M. L. Newhouse, Robert Corringham, D N Baron, H. G. Prentice, M. J. M. L. Gilmore, H. G. Prentice and Hilary Blacklock. Their work appears in journals such as Cancer, International Journal of Gynecology & Obstetrics, Journal of Epidemiology & Community Health, Breast Cancer Research and Treatment and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026